MX:1093N Stock Latest News
Company AnnouncementsCSPC Reports Nine-Month Revenue and Profit Growth in 202614h ago
Company AnnouncementsCSPC Initiates China Trial of SYH2051 Combination Therapy2d ago
Pre-EarningsCHJTF Upcoming Earnings Report: What to Expect?2d ago
Pre-EarningsCHJTF Earnings Report this Week: Is It a Buy, Ahead of Earnings?1w ago
Company AnnouncementsCSPC Starts Phase II Trial of Inhaled IPF Drug in China1w ago
Company AnnouncementsCSPC Sets Board Meeting to Review Nine-Month Results1w ago
Company AnnouncementsCSPC Begins Phase II China Trial of SYH2072 for Hypertension2w ago
Company AnnouncementsCSPC Initiates China Phase I/II Trial of SYS6088 Cancer Therapy2w ago
Company AnnouncementsCSPC Begins Phase I Trial of Recombinant RSV Vaccine in China2w ago
Company AnnouncementsCSPC Begins Phase I/II Trial of SYS6052 Herpes Zoster Vaccine2w ago
Company AnnouncementsCSPC Diabetes Triple Therapy Achieves Positive Phase III Results2w ago
Company AnnouncementsCSPC Innovation Posts Strong Nine-Month Revenue and Profit Surge3w ago
Company AnnouncementsCSPC’s Novel Immuno-Oncology Drug Shows Early Promise in Advanced Solid Tumours3w ago
Company AnnouncementsCSPC’s B7-H3 ADC Shows Strong Phase I/II Results in Advanced Breast Cancer3w ago
Company AnnouncementsCSPC’s Anbenitamab Delivers Major Survival Gain in HER2-Positive Gastric Cancer Trial3w ago
Company AnnouncementsCSPC’s Anbenitamab Combo Delivers Superior Results in HER2-Positive Breast Cancer Trial3w agoCompany AnnouncementsCSPC Wins China Approval for First-in-Class Batoclimab Therapy in Myasthenia Gravis3w ago


